BioLineRx Ltd. (NASDAQ: BLRX) announced today that it has acquired Agalimmune Ltd., a private UK-based company with an innovative, anti-cancer ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE